Geneva, Aug. 29 -- International Clinical Trials Registry received information related to the study (NCT07123506) titled 'Beta-blockers for Prevention of Supraventricular Arrhythmia Following PFO Closure' on Aug. 7.
Study Type: Interventional
Study Design:
Allocation: Randomized. Intervention model: Single Group Assignment. Primary purpose: Treatment. Masking: None (Open Label).
Primary Sponsor: Yonsei University
Condition:
Atrial Fibrillation
Atrial Flutter
Tachycardia, Supraventricular
Heart Septal Defects, Atrial
Intervention:
Drug: Beta-blocker treatment group
Recruitment Status: Not recruiting
Phase: N/A
Date of First Enrollment: September 2025
Target Sample Size: 350
Countries of Recruitment:
Korea, Republic of
To ...